Solubility of Pharmaceutical Solids

2011 ◽  
pp. 21-38
Author(s):  
Lauren Wiser ◽  
Xiaoling Gao ◽  
Bhaskara Jasti ◽  
Xiaoling Li
2021 ◽  
Vol 138 ◽  
pp. 116228
Author(s):  
Amanpreet Kaur ◽  
Dnyaneshwar P. Kale ◽  
Arvind K. Bansal

2002 ◽  
Vol 206 (1-3) ◽  
pp. 547-554 ◽  
Author(s):  
D Zhang ◽  
J.H Flory ◽  
S Panmai ◽  
U Batra ◽  
M.J Kaufman

Author(s):  
Susan M. Reutzel-Edens ◽  
Doris E. Braun ◽  
Ann W. Newman

2012 ◽  
Vol 14 (3) ◽  
pp. 380-388 ◽  
Author(s):  
Ye Sun ◽  
Lei Zhu ◽  
Tian Wu ◽  
Ting Cai ◽  
Erica M. Gunn ◽  
...  

2021 ◽  
Vol 54 (5) ◽  
Author(s):  
Qin Shi ◽  
Fang Li ◽  
Jia Xu ◽  
Lingling Wu ◽  
Junbo Xin ◽  
...  

Physical stability is one of the main challenges when developing robust amorphous pharmaceutical formulations. This article reports fast crystal growth behaviors of the γ and α forms of indomethacin (IMC) initiated by bubbles in the interior of a supercooled liquid. Bubble-induced crystal growth of γ-IMC exhibits approximately the same kinetics as its surface crystal growth, supporting the view that bubble-induced crystal growth is a surface-facilitated process. In contrast, the rates of bubble-induced crystal growth of α-IMC are much faster than those of its surface crystal growth. These results indicate that the bubble-induced crystal growth not only depends on the interface created by the bubble but also strongly correlates with the true cavitation of the bubble. Moreover, bubble-induced fast crystal growth of γ- and α-IMC can be terminated at different temperatures by cooling. These outcomes are meaningful for the in-depth understanding of physical stability and pre-formulation study of amorphous pharmaceutical solids showing surface-facilitated crystal growth.


Pharmaceutics ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 457 ◽  
Author(s):  
Dattatray Modhave ◽  
Brenda Barrios ◽  
Amrit Paudel

Reactive impurities, such as hydrogen peroxide in excipients, raise a great concern over the chemical stability of pharmaceutical products. Traditional screening methods of spiking impurities into solid drug-excipient mixtures oversimplify the micro-environment and the physical state of such impurities in real dosage form. This can lead to an inaccurate prediction of the long-term product stability. This study presents the feasibility of using a polyvinylpyrrolidone-hydrogen peroxide complex (PVP-H2O2) as an oxidative agent for the solid state forced degradation of a selected drug, vortioxetine HBr. The PVP-H2O2 complex was prepared and characterized using FT-IR spectroscopy. The tablet compacts were made using a mixture of solid PVP-H2O2 complex and crystalline vortioxetine HBr powder. The compacts were exposed to 40 °C/75% RH condition in open and closed states for different time intervals. The extent and the type of drug degradation were analysed using LC and LC-MS. The extent of degradation was higher in the samples stored at the open state as compared to the close state. The solution state forced oxidation was conducted to verify the peroxide induced degradation reactions. The results evidence the utility of the proposed solid-state stressor and the method for screening the sensitivity of drugs to the excipient reactive impurities involving peroxides in solid-state.


2019 ◽  
Vol 91 (9) ◽  
pp. 6217-6224 ◽  
Author(s):  
Xingyu Lu ◽  
Daniel Skomski ◽  
Karen C. Thompson ◽  
Michael J. McNevin ◽  
Wei Xu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document